Literature DB >> 17048060

Leukocyte removal therapy before surgery in ulcerative colitis.

Toshiyuki Matsui.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 17048060     DOI： 10.1007/s00535-006-1898-7

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN： 0944-1174            Impact factor:   7.527


× No keyword cloud information.
  16 in total

1.  Leukocyte removal filter-passed lymphocytes produce large amounts of interleukin-4 in immunotherapy for inflammatory bowel disease: role of bystander suppression.

Authors:  M Noguchi; N Hiwatashi; T Hayakawa; T Toyota
Journal:  Ther Apher       Date:  1998-05

2.  Fluctuations in the peripheral blood leukocyte and platelet counts in leukocytapheresis in healthy volunteers.

Authors:  Ken Yamaji; Kwangseok Yang; Hiroshi Tsuda; Hiroshi Hashimoto
Journal:  Ther Apher       Date:  2002-12

3.  Surgery in patients on long-term steroid therapy: a tentative model for risk assessment.

Authors:  R Reding; L A Michel; J Donckier; L de Canniere; J Jamart
Journal:  Br J Surg       Date:  1990-10       Impact factor: 6.939

4.  Severe steroid-unresponsive ulcerative colitis: outcomes of restorative proctocolectomy in patients undergoing cyclosporin treatment.

Authors:  M Pinna-Pintor; P Arese; R Bona; E Falletto; R Schieroni; E Villata; N Massaioli; P Selvaggi; G C Actis; M Lagget; A Marzano; A Ottobrelli; R Sostegni; M R Torrani-Cerenzia; M Rizzetto
Journal:  Dis Colon Rectum       Date:  2000-05       Impact factor: 4.585

5.  Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study.

Authors:  T Shimoyama; K Sawada; N Hiwatashi; T Sawada; K Matsueda; A Munakata; H Asakura; T Tanaka; R Kasukawa; K Kimura; Y Suzuki; Y Nagamachi; T Muto; H Nagawa; B Iizuka ; S Baba; M Nasu; T Kataoka; N Kashiwagi; A R Saniabadi
Journal:  J Clin Apher       Date:  2001       Impact factor: 2.821

6.  Cyclosporin for severe ulcerative colitis does not increase the rate of perioperative complications.

Authors:  G M Hyde; D P Jewell; M G Kettlewell; N J Mortensen
Journal:  Dis Colon Rectum       Date:  2001-10       Impact factor: 4.585

7.  Leukocytapheresis in ulcerative colitis: results of a multicenter double-blind prospective case-control study with sham apheresis as placebo treatment.

Authors:  Koji Sawada; Kazuo Kusugami; Yasuo Suzuki; Tadao Bamba; Akihiro Munakata; Toshifumi Hibi; Takashi Shimoyama
Journal:  Am J Gastroenterol       Date:  2005-06       Impact factor: 10.864

8.  Decrease of reactive-oxygen-producing granulocytes and release of IL-10 into the peripheral blood following leukocytapheresis in patients with active ulcerative colitis.

Authors:  Hiroyuki Hanai; Takayuki Iida; Ken Takeuchi; Fumitoshi Watanabe; Yasuhiko Maruyama; Masataka Kikuyama; Tatsuo Tanaka; Kenji Kondo; Kou Tanaka; Kenji Takai
Journal:  World J Gastroenterol       Date:  2005-05-28       Impact factor: 5.742

9.  Modulation of platelet aggregation responses by leukocytapheresis therapy in patients with active ulcerative colitis.

Authors:  Yuhki Yagi; Akira Andoh; Osamu Inatomi; Shigeki Bamba; Tomoyuki Tsujikawa; Yoshihide Fujiyama; Keiichi Mitsuyama; Takashi Yoshida
Journal:  J Gastroenterol       Date:  2006-06       Impact factor: 7.527

10.  Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients.

Authors:  Faten N Aberra; James D Lewis; David Hass; John L Rombeau; Benjamin Osborne; Gary R Lichtenstein
Journal:  Gastroenterology       Date:  2003-08       Impact factor: 22.682
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.